Clinical Trials Directory

Trials / Completed

CompletedNCT01261897

The Efficacy of Adductor-Canal-Blockade on Pain and Morphine Consumption After Total Knee Arthroplasty

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
40 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to assess the efficacy of Adductor-Canal-Blockade on pain and morphine consumption after total knee arthroplasty. Our hypothesis is that the Adductor -Canal-Blockade is superior to placebo in reducing pain and morphine consumption after total knee arthroplasty.

Conditions

Interventions

TypeNameDescription
PROCEDUREAdductor-Canal-Blockade with RopivacaineUS-guided Adductor-Canal-Blockade with ropivacaine 7,5 mg/ml
PROCEDUREAdductor-Canal-blockade with salineUS-guided Adductor-Canal-blockade with saline

Timeline

Start date
2011-01-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2010-12-17
Last updated
2011-10-04

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01261897. Inclusion in this directory is not an endorsement.

The Efficacy of Adductor-Canal-Blockade on Pain and Morphine Consumption After Total Knee Arthroplasty (NCT01261897) · Clinical Trials Directory